Short Interest in Lonza Group AG (OTCMKTS:LZAGY) Increases By 566.7%

Lonza Group AG (OTCMKTS:LZAGY) saw a significant increase in short interest in the month of August. As of August 31st, there was short interest totalling 2,000 shares, an increase of 566.7% from the August 15th total of 300 shares. Based on an average trading volume of 64,300 shares, the days-to-cover ratio is presently 0.0 days.

Analyst Ratings Changes

Separately, Berenberg Bank raised shares of Lonza Group to a “strong-buy” rating in a report on Sunday, June 23rd.

Lonza Group Price Performance

OTCMKTS LZAGY traded up $1.44 on Friday, reaching $65.43. The company’s stock had a trading volume of 27,792 shares, compared to its average volume of 89,770. Lonza Group has a twelve month low of $34.19 and a twelve month high of $67.00. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.77 and a quick ratio of 1.20. The firm’s 50 day moving average is $62.79 and its two-hundred day moving average is $58.37.

Lonza Group Company Profile

Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments. The Biologics segment engages in the contract development and manufacturing of biopharmaceuticals for clinical and commercial manufacturing needs throughout the product lifecycle, including drug substance and drug product manufacturing.